Concepedia

Author

Lynda B. Davern

Bristol-Myers Squibb (United States)

Also Known As

L B Davern, L. B. Davern, L. Davern, Lynda B Davern, Lynda B. Davern, Lynda Beth Davern, Lynda Davern

14

Publications

344

Citations

11

H-Index

35

Concepts

All Affiliations

Bristol-Myers Squibb (United States)University at Buffalo, State University of New YorkBristol-Myers Squibb (Germany)
LB

About

Lynda B. Davern is an author at Bristol-Myers Squibb (United States) specializing in medicine, immunology, and clinical microbiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

199

2

Natural Sciences

2

2

56

3

Cell Biology

2

2

56

4

Allergy

1

1

10

5

Biochemistry

1

1

42

Lynda B. Davern

×

12

Publications

331

Citations

11

H-Index

YearCitations

Protective immunization against experimental Bacteroides (Porphyromonas) gingivalis infection

P B Chen, Lynda B. Davern, Robert E. Schifferle,

Infection and Immunity

1990

69

Phosphorylation and calcium influx are not sufficient for the activation of cytosolic phospholipase A2 in U937 cells: Requirement for a Giα-type G-protein

James R. Burke, Lynda B. Davern, Kurt R. Gregor,

Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology

1997

42

BMS-229724 Is a Tight-Binding Inhibitor of Cytosolic Phospholipase A2 That Acts at the Lipid/Water Interface and Possesses Anti-Inflammatory Activity in Skin Inflammation Models

James R. Burke, Lynda B. Davern, Paul Stanley,

Journal of Pharmacology and Experimental Therapeutics

2001

31

Host responses induced by co‐infection with <i>Porphyromonas gingivalis</i> and <i>Actinobacillus actinomycetemcomitans</i> in a murine model

P. B. Chen, Lynda B. Davern, Jannet Katz,

Oral Microbiology and Immunology

1996

29

Inhibitor of phospholipase A2 blocks eicosanoid and platelet activating factor biosynthesis and has topical anti-inflammatory activity.

Kenneth M. Tramposch, Floyd H. Chilton, Paul Stanley,

Journal of Pharmacology and Experimental Therapeutics

1994

29

Experimental Porphyromonas gingivalis infection in nonimmune athymic BALB/c mice

P B Chen, Lynda B. Davern, Alfredo Aguirre

Infection and Immunity

1991

28

Analysis of <i>in vitro</i> lymphoproliferative responses and antibody formation following subcutaneous injection of <i>Actinobacillus</i> actinomycetemcomitans and Wolinella recta in a murine model

Priscilla B. Chen, Lynda B. Davern, Mirdza E. Neiders,

Oral Microbiology and Immunology

1991

24

BMS-190394, a Selectin Inhibitor, Prevents Rat Cutaneous Inflammatory Reactions

Gordon Todderud, Xina Nair, Debbie Lee,

Journal of Pharmacology and Experimental Therapeutics

1997

22

Modification of experimental <i>Porphyromonas gingivalis</i> murine infection by immunization with a polysaccharide‐protein conjugate

Robert E. Schifferle, P. B. Chen, Lynda B. Davern,

Oral Microbiology and Immunology

1993

21

Differentiation of U937 Cells Enables a Phospholipase D-Dependent Pathway of Cytosolic Phospholipase A2 Activation

James R. Burke, Lynda B. Davern, Kurt R. Gregor,

Biochemical and Biophysical Research Communications

1999

14

Page 1